1 mg/1 ml

DRUG3 trials

Sponsors

Ferring Pharmaceuticals A/S, Universitair Ziekenhuis Gent, UZ Brussel

Conditions

Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cyclePrevention of female infertility.Subfertility

Phase 3

A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response after controlled ovarian stimulation with mixed protocols of follitropin delta (REKOVELLE) and highly purified human menopausal gonadotropin (MENOPUR) in women undergoing an assisted reproductive technology programme

Not yet recruitingCTIS2022-500308-23-00

Ferring Pharmaceuticals A/SInfertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle

Target: 115Updated: 2022-11-09

Phase 4

PPOS and CFA for elective Freeze-All ovarian stimulation cycles: a prospective cross-over study

RecruitingCTIS2023-506694-35-00

Universitair Ziekenhuis GentSubfertility

Start: 2025-01-24Target: 60Updated: 2025-04-09

RAndom sTArT Ovarian stimUlatIon (RSOS) in eLective oocyte cryopreservation cycLEs (RATATOUILLE): a single-center, non-inferiority, randomised controlled trial

RecruitingCTIS2023-509919-89-00

UZ BrusselPrevention of female infertility.

Start: 2025-02-19Target: 277Updated: 2025-02-05